PURCHASE
Publication Only | Archived Video + e-Materials
DESCRIPTION
Hear from experienced litigators from both the generic and brand sides as well as in-house counsel and the Bench on best practices for litigating under the Patented Medicines (Notice of Compliance) Regulations. Our expert faculty will assist you to conduct proceedings under the Regulations efficiently and in a cost-effective manner, and will provide valuable insights on the current state of pharmaceutical and biosimilar litigation in Canada.
PROGRAM CHAIRS
Geoff Mowatt, Dimock Stratton LLP
Vincent de Grandpré, Osler Hoskin Harcourt LLP
TABLE OF CONTENTS
Meeting Counsel Expectations PowerPoint Slides
David Blais, Mylan Pharmaceuticals ULC
Denise Lacombe, AstraZeneca Canada Inc.
Framing a Winning Notice of Allegation PowerPoint Slides
Dino Clarizio, Goodmans LLP
David Reive, Miller Thomson LLP
Getting a Strategic Advantage: Court Filings and Interlocutory Matters
Fiona Legere, McCarthy Tétrault LLP
Kavita Ramamoorthy, Deeth Williams Wall LLP
Getting a Strategic Advantage: Court Filings and Interlocutory Matters PowerPoint Slides
Fiona Legere, McCarthy Tétrault LLP
Kavita Ramamoorthy, Deeth Williams Wall LLP
Lessons from Recent Experimental Testing Cases
Jordana Sanft, Norton Rose Fulbright Canada LLP
Sana Halwani, Gilbert's LLP
Building the Foundation of Your Case PowerPoint Slides
Jordana Sanft, Norton Rose Fulbright Canada LLP
Sana Halwani, Gilbert's LLP
The Art (But Mostly Science) Of Cross-Examination in PM(NOC) Proceedings
Dominique Hussey, Bennett Jones LLP
Mark Davis, Belmore Neidrauer LLP
Imagining Litigation Under Better Regulations
Nathaniel Lipkus, Osler, Hoskin & Harcourt LLP
Andrew Bernstein, Torys LLP
Preparing for and Conducting a Successful Hearing PowerPoint Slides
Scott Beeser, Aitken Klee LLP
Christopher Van Barr, Gowling WLG